., Rodrguez-Gascn, A., Almeida, A
Our goal is to give patients multiple evidence-based options so they can choose the treatment that best fits their lifestyle, preferences, health needs, and price point to make long-term use a viable option. Amy Sheer, MD, MPH, DABOM MNT also spoke with George W
The STEP clinical trial program alone involved over 4,500 participants across multiple studies
Arguably, this may signal the beginning of an overdue shakeout as we start moving past peak hype in obesity
Participants consistently described GLP-1s as a tool that enabled healthier behaviours rather than replacing them. Expanding access to effective medications, she added, should go hand in hand with sustained investment in behavioural support and obesity prevention if the goal is meaningful, long-term improvement in metabolic health
Accessed May 31, 2020